Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation

Coronary Artery Disease

Volumn 22, Issue 3, 2011, Pages 199-205

  Rossini, Roberta ^a   Capodanno, Davide ^b   Musumeci, Giuseppe ^a   Lettieri, Corrado ^c   Lortkipanidze, Nikoloz ^a   Romano, Michele ^c   Nijaradze, Tamar ^a   Tarantini, Giuseppe ^d   Cicorella, Nicola ^c   Sirbu, Vasile ^a   Guagliumi, Giulio ^a   Rosiello, Renato ^c   Valsecchi, Orazio ^a   Gavazzi, Antonello ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CARLO POMA HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiplatelets; bleeding; clopidogrel; drug eluting stents; proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG FATALITY; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL; RISK ASSESSMENT; STENT THROMBOSIS; STROKE; TREATMENT DURATION;

ACUTE CORONARY SYNDROME; AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; COHORT STUDIES; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 79955075900     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328343b03a     Document Type: Article

References (22)

1. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA,Williams DO, et al. 2007 Focused update of the ACCAHASCAI 2005 guideline update for percutaneous coronary intervention a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines 2007 Writing Group to Review New Evidence and Update the ACCAHASCAI 2005 Guideline Update for Percutaneous Coronary Intervention, writing on behalf of the 2005 writing committee. Circulation 2008; 117261-295.
2. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention the PCI-CURE study. Lancet 2001; 358527-533.
3. Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention a randomized controlled trial. JAMA 2002; 2882411-2420. (Pubitemid 35340537)
4. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCFACGAHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 1181894-1909.
5. Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. J Thromb Haemost 2006; 42508-2509.
6. Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study. J Am Coll Cardiol 2008; 51256-260.
7. Ho PM, Maddox TM,Wing L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301937-944.
8. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180713-718.
9. Bhatt DL, Cryer B, Contant CF, Cohen M, Lanas A, Schnitzer TJ, et al.; For the COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010; 3631909-1917.
10. O'Donoghue ML, Braunwalk E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor an analysis of two randomised trials. Lancet 2009; 374 989-997.
11. Ray W, Murray K, Griffin M, Chung CP, Smalley WE, Hall K, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors. Ann Intern Med 2010; 152337-345.
12. Gaglia M, Torguson R, Hanna N, Gonzalez MA, Collins SD, Syed AI, et al. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes. Am J Cardiol 2010; 105833-838.
13. Rossini R, Capodanno D, Lettieri C, Musumeci G, Nijaradze T, Romano M, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107186-194.
14. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 3561020-1029.
15. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis In Myocardial Infarction (TIMI) Trial - phase I hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 111-11.
16. Rassen J, Choudhry N, Avorn J, Schneeweiss S. Proton pump inhibitors after percutaneous coronary intervention or acute cardiovascular outcomes and mortality in patients using clopidogrel with acute coronary syndrome. Circulation 2009; 1202322-2329.
17. Stockl K, Le L, Zakharyan A, Harada A, Solow B, Addiego J, Ramsey S. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med 2010; 170704-710.
18. Siller-Matula JM, Jilma B, Schrö r K, Christ G, Huber K. Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel a systematic review and meta-analysis. J Thromb Haemost 2010; doi 10.1111j.1538-7836.2010.04049. [Epub ahead of print].
19. Li XQ, Andersson TB, Ahlstrom M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 2004; 32821-827.
20. Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009; 101714-719.
21. Kwok C, Loke Y. Meta-analysis the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 2010; 31810-823.
22. Angiolillo DJ, Gibson CM, Cheng S, Ollier C, Nicolas O, Bergougnan L, et al. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther 2011; 8965-74.